Preterm Birth Prevention and Management Market to See over 9% CAGR Through 2029; Hydroxyprogesterone Sales Ramp up, Says a New FMI Report

The global preterm birth prevention and management market surpassed the valuation of US$ 1 Bn in 2019, with growth projected to see a robust CAGR of more than 9% through 2029. The preterm birth prevention drugs industry is observing a substantial surge in number of FDA-approved new generic copies of blockbuster drugs every year. This can be primarily attributed to favorable government policy framework and demographics, orphan drug designations, adoption of new combination therapies, and complications in the selection of one line of therapy.

Key Takeaways of the Study

  • Development of higher complexity specific portfolios and consistent focus on areas of strength while working pipelines are the cornerstone for success in the preterm birth prevention market space.
  • Ensuring preterm interventions and research given proportional focus, so funding is aligned with health burden to curb the mortality rate
  • Makena, with various approvals for the treatment of preterm birth in potential female patient pool, contributed to the dominance of the progesterone therapy segment by therapy type in 2018 and continue to do so during the forecast period.
  • Highly effective therapies with cost advantage over are expected to generate significant revenue in the long run.
  • Majority of the global preterm birth cases have not been directed towards preterm diagnostic leading to higher mortality rates and complications
  • Sale of Hydroxyprogesterone over antihypertensive drugs such as Nifedipine, and labetalol in the global preterm birth prevention and management market has increased drastically owing to quicker onset of action and higher efficacy.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-6457

Launch of Cost-effective Therapies Bodes Well for Market

New revenue opportunities in developed economies, and orphan drug designation by FDA are contributing significantly towards the launch of cost-effective therapies. A few other factors assisting the growth of preterm birth prevention and management market include adoption of preterm diagnostic tests and the economic burden of premature birth on the system.

Frequent drug shortages and unavailability of life-saving formulations in many parts of the country, growing initiatives by government and manufacturers for supply of life-saving preterm birth drugs, particularly in low income and developing countries, are driving the market growth.

Strategic Acquisitions by Key Players to Widen Regional Presence

The leading players in the preterm birth prevention and management market such as AMAG Pharmaceuticals, Pfizer Inc., and Mylan, are concentrating on organic revenue growth and commercial expansions by mergers and distribution agreements and capturing the untapped potential of the preterm birth prevention and management market.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-6457

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Leave a comment

Your email address will not be published. Required fields are marked *